Bio News
Researchers at the University of Chicago successfully inhibited pancreatic cancer growth and activated CD8+ T cells that attack cancer cells using probiotics loaded with modified interleukin-2 (IL-2). The probiotics were designed to proliferate and release IL-2 only inside tumors, where oxygen levels are low, increasing treatment efficacy while minimizing systemic adverse effects. In animal studies, combining the probiotics with chemotherapy, radiation therapy and other treatments produced greater effects than administration alone, and safety evaluations in humans are planned for the future.
BIOBOOK TEAM
biobookmedia@biobook.co.krRural Development Administration Develops Two Molecular Markers to Identify Leaf Splitting in Squash
MFDS Begins Distribution of Internationally Certified Reference Materials, Including 24 New Items, for a Total of 882
Ministry of Trade, Industry and Energy signs agreement to promote biotech and medical devices in Gangwon; site visit set for the 14th
RDA develops technology to produce anti-inflammatory exosomes for pets and files patent application
HLB Submits FDA Resubmission for First-Line Liver Cancer Treatment
Celltrion Reports Third-Quarter Revenue of 1.5 Trillion Won and Operating Profit of 510 Billion Won, Up 69% Year Over Year
Rural Development Administration Develops Two Molecular Markers to Identify Leaf Splitting in Squash
MFDS Begins Distribution of Internationally Certified Reference Materials, Including 24 New Items, for a Total of 882
Ministry of Trade, Industry and Energy signs agreement to promote biotech and medical devices in Gangwon; site visit set for the 14th
